Publication | Open Access
Tegaserod has a favorable safety & tolerability profile in patients with constipation predominant and alternating forms of irritable bowel syndrome (IBS)
27
Citations
0
References
2000
Year
Food IntoleranceFunctional Gastrointestinal DisorderGastrointestinal PharmacologyMedicinePharmacologyGastroenterologyFavorable SafetyConstipation PredominantClinical GastroenterologyIrritable Bowel SyndromeDigestive System Diseases
No additional data available for this publication yet. Check back later!